Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.
Veronesi A, Magri MD, Tirelli U, Carbone A, Mazza F, Franceschi S, Talamini R, Ardizzoni A, Canobbio L, Rosso R, et al. Veronesi A, et al. Among authors: rosso r. Am J Clin Oncol. 1988 Oct;11(5):566-71. doi: 10.1097/00000421-198810000-00012. Am J Clin Oncol. 1988. PMID: 2845769 Clinical Trial.
A phase II study with danazol in metastatic breast cancer.
Pronzato P, Amoroso D, Ardizzoni A, Bertelli G, Conte PF, Michelotti A, Rosso R. Pronzato P, et al. Among authors: rosso r. Am J Clin Oncol. 1987 Oct;10(5):407-9. doi: 10.1097/00000421-198710000-00008. Am J Clin Oncol. 1987. PMID: 3661491
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Ardizzoni A, Salvati F, Rosso R, Bruzzi P, Rubagotti A, Pennucci MC, Mariani GL, De Marinis F, Pallotta G, Antilli A, et al. Ardizzoni A, et al. Among authors: rosso r. Cancer. 1993 Nov 15;72(10):2929-35. doi: 10.1002/1097-0142(19931115)72:10<2929::aid-cncr2820721012>3.0.co;2-x. Cancer. 1993. PMID: 8221559 Clinical Trial.
Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.
Ardizzoni A, Pennucci MC, Danova M, Viscoli C, Mariani GL, Giorgi G, Venturini M, Mereu C, Scolaro T, Rosso R. Ardizzoni A, et al. Among authors: rosso r. Br J Cancer. 1996 Oct;74(7):1141-7. doi: 10.1038/bjc.1996.504. Br J Cancer. 1996. PMID: 8855989 Free PMC article. Clinical Trial.
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Baldini E, Tibaldi C, Ardizzoni A, Salvati F, Antilli A, Portalone L, Barbera S, Romano F, De Marinis F, Migliorino MR, Noseda MA, Borghini U, Crippa M, Ferrara G, Raimondi M, Fioretti M, Bandera M, Pennucci MC, Galeasso G, Cacciani GC, Lepidini G, Sunseri G, Lanfranco C, Rinaldi M, Rosso R, et al. Baldini E, et al. Among authors: rosso r. Br J Cancer. 1998 Jun;77(12):2367-70. doi: 10.1038/bjc.1998.393. Br J Cancer. 1998. PMID: 9649160 Free PMC article. Clinical Trial.
866 results